The new device can inject a range of drugs of different viscosities up to 35cP and different fill volumes up to 1mL.
Becton, Dickinson, and Company (BD), a medical technology company based in Switzerland, introduced the BD Intevia, a 1-mL two-step disposable autoinjector that combines an autoinjector and pre-fillable syringe into one platform device.
According to an Oct. 21, 2019 press release, the new device can inject a range of drugs of different viscosities up to 35cP and different fill volumes up to 1 mL. It comes equipped with a two-step, push-on-skin activation option for patient control and feedback indicators that alert the patients when the dose has been delivered and triggers an audible click. The design also allows the pharmaceutical industry to use the device without customizing its system components.
“BD Intevia is a new generation of BD autoinjectors that will help drug manufacturers seamlessly enhance drug delivery experience,” said Peter Nolan, worldwide president, BD Medical-Pharmaceutical Systems, in the press release. “For the patient, the platform technology is designed to promote patient ease of use when self-injecting, and it is supported by BD’s worldwide clinical injection expertise harnessing the latest research in drug delivery technology.”
BD will showcase its products at Stand 111C70 at CPhI Worldwide from Nov. 5–7 in Frankfurt, Germany.
Source: BD
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.